← All trials
NCT05259007
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Feb 22, 2022
- Primary completion
- Mar 23, 2022
- Completion date
- Apr 5, 2022
- First posted
- Feb 28, 2022
- Last posted
- Feb 28, 2022
- Enrollment
- 96
- Arms / groups
- 3 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Istanbul Medipol UniversityLead sponsor
- Istanbul Medipol UniversitySponsor investigator
- Apipark BeekeepingCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.